Intellectual Property - Sensoril®
US 7,318,938: Withania somnifera composition, method for
obtaining same and pharmaceutical, nutritional and personal care
formulations thereof
US 6,713,092 B1: Withania somnifera composition, method for
obtaining same and pharmaceutical, nutritional and personal care
formulations thereof
US 6,153,198: Withania somnifera composition
EP1569669 A2:Withania somnifera composition, method for
obtaining same and pharmaceutical, nutritional and personal care
formulations thereof
Canadian Patent No. 2,508,478 – Withania somnifera composition,
method for obtaining same and pharmaceutical, nutritional and
personal care formulations thereof
US 8,206,757: Combination of Ashwagandha and Indian
Gooseberry
Other pending US and PCT applications
7
CONFIDENTIA
L
Human clinical study of Sensoril® for stress
management
o
Number of patients
o
Randomized placebo-controlled double blind study
,
,
o
130 chronically stressed subjects enrolled; 98 completed
o
Treatment schedule
•
Group 1: Sensoril
®
(250 mg capsule; 2/day)
•
Enrolled 35; Completed 34
•
Group 2: Sensoril
®
(125 mg capsule; 2/day)
•
Enrolled 35; Completed 30
•
Group 3: Sensoril® (125 mg capsule; 1/day)
•
Enrolled 30; Completed 19
•
Group 4: Placebo (2/day)
•
Enrolled 30; Completed 15
•
Comprehensive assessments done at
0 day, after 30 and 60 days treatment
Published: JANA, Vol. II, No.1, 208, Pages 50-56
.
8
CONFIDENTIA
L
